{
  "retracted": true,
  "timestamp": 1483228800000,
  "updates": [
    {
      "timestamp": 1495664273787,
      "identifier": {
        "doi": "10.1016/j.jhep.2016.10.020"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/s0168-8278(16)01707-4"
  },
  "journal": "Journal of Hepatology",
  "publisher": "Elsevier BV",
  "title": "Retraction notice to: PS124â€“Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (PSC) in Individuals with Inflammatory Bowel Disease [J Hepatol 64 (2016) S199]"
}
